martes, 24 de noviembre de 2015

NGC Update Service: November 23, 2015 ► Announcements

NGC Update Service: November 23, 2015

National Guideline Clearinghouse (NGC)

Announcements



Conference News

  • The 8th Annual Conference on the Science of Dissemination and Implementation will take place from December 14-15, 2015 in Washington DC. The theme is "Optimizing Personal and Population Health." Visit theconference home page for more information.
  • The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, are available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisories

  • November 6, 2015Plavix (clopidogrel): An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease. FDA evaluation of the Dual Antiplatelet Therapy (DAPT) trial and several other clinical trials also does not suggest that clopidogrel increases the risk of cancer or death from cancer.
  • November 17, 2015Iodine-containing Contrast Agents for Medical Imaging: FDA is advising that rare cases of underactive thyroid have been reported in infants following the use of contrast media containing iodine, also called "contrast dye," for X-rays and other medical imaging procedures. In all of the reported cases, the infants were either premature or had other serious underlying medical conditions. Available evidence leads FDA to believe that this rare occurrence is usually temporary and resolves without treatment or any lasting effects. See the Drug Safety Communication for a data summary and a list of approved Approved Iodinated Contrast Media Products

Health Awareness Topics - November 2015

How to Participate

  • Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
  • Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC.

No hay comentarios: